Longevity, life expectancy and healthy life expectancy Professor Sarah Harper University of Oxford IARU Unviersity of Tokyo 2016年 12月 20日 Worlds 1st Super- centenarion Geert Adriaans Boomgaard Oxford Institute of Population Ageing Worlds 1st Super- centenarion FOUGHT WITH NAPOLEAN…. Geert Adriaans Boomgaard 21 September 1788 Groningen, Netherlands 3 February 1899 110 years 135 days Record male life until 1966 Oxford Institute of Population Ageing § Jeanne Calment of France, who died in 1997 aged 122 years, 164 days, had the longest human lifespan documented. § The oldest verified man ever recorded is Jiroemon Kimura of Japan, who died in 2013 aged 116 years and 54 days Oxford Institute of Population Ageing § Will increases in both life expectancy and in life extension or longevity continue? § § Will life expectancy increase in line with life extension? § § will we all enjoy the benefits of longevity or will it be for a few? Will increases in life expectancy be accompanied by increases in life extension or are we seeing a compression of longevity after 100? § § will there be an increase in average years lived by humans and also maximum years attained by a human being? will the predicted increases in centenarians over the coming century be accompanied by increases in super-centenarians? Will advances in life expectancy be matched by advances in healthy life expectancy? Oxford Institute of Population Ageing Life expectancy, selected OECD countries, men and women, birth Birth 88 Japanwomen Remainingyearsoflife 86 Francewomen 84 UKwomen 82 USAwomen Japanmen 80 Francemen 78 UKmen 76 USAmen 74 72 2000 2001 2002 Source:OECD 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 Life expectancy, selected OECD countries, men and women, age 65 Age65 Remainingyearsoflife 25 24 Japanwomen 23 Francewomen UKwomen 22 USAwomen 21 Japanmen 20 Francemen 19 UKmen 18 USAmen 17 16 15 2000 2001 2002 Source:OECD 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 Life expectancy, selected OECD countries, men and women, age 80 Age80 12 Japanwomen 11 Francewomen Remainingyearsoflife UKwomen 10 USAwomen Japanmen 9 Francemen 8 UKmen USAmen 7 6 2000 2001 Source:OECD 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 Proportion of persons surviving to successive ages 1.0 0.9 1991 1971 1951 1931 Proportion surviving 0.8 0.7 2011 1911 1891 1871 0.6 1851 0.5 0.4 0.3 0.2 0.1 0.0 0 10 20 30 40 50 Age 60 70 Oxford Institute of Population Ageing 80 90 100 110 Source: ONS / Oxford Institute of Population Ageing UK Male Mortality 1911-2005 10,000 9,000 !"#$%&'"() *$(+,-./'-0) 1."%$-() 1,-%23./'-0) 8,000 Deaths per million adults 7,000 6,000 5,000 4,000 3,000 2,000 1,000 0 1911 1921 1931 1941 1951 1961 1971 1981 1991 Source: ONS / Oxford Institute of Population Ageing Oxford Institute of Population Ageing Prevalence of obesity (BMI > 30), age 50+ 40 35 30 25 20 15 10 5 0 Source: US Centers for Disease Control Oxford Institute of Population Ageing Effect of Obesity on Female Life Expectancy Mehta/Chang: 22% of female at age 5041% of female gap PSC: 1.8 gap PSC 1.6 Mehta/Chang 1.4 1.2 1 0.8 0.6 0.4 0.2 0 US France Italy Netherlands Spain Denmark Canada England Source: Prospective Studies Collaboration (PSC); Mehta and Chang (2010) from Preston and Stokes “Is the High Level of Obesity in the United States Related to Its Low Life Expectancy?” 2010 Oxford Institute of Population Ageing Picture: Colourbox Oxford Institute of Population Ageing Public Health Age 55 Reduced LE Increased DY Obesity 1.4 5.9 Smoking 4 3.8 Alcohol 3 3.1 (Klijs et al., 2011a). Oxford Institute of Population Ageing Will increases in both life expectancy and in life extension or longevity continue? will there be an increase in average years lived by humans and also maximum years attained by a human being? Will life expectancy increase in line with life extension? will we all enjoy the benefits of longevity or will it be for a few? The Inequality question Will increases in life expectancy be accompanied by increases in life extension or are we seeing a compression of longevity after 100? !! Will advances in life expectancy be matched by advances in healthy life expectancy? Oxford Institute of Population Ageing Will advances in life expectancy be matched by advances in healthy life expectancy? Relationship of life expectancy healthy life expectancy: Compression of morbidity: HLE increasing faster than LE expectancy - extra years of life are healthy ones Expansion of morbidity: HLE not pacing LE - extra years of life are unhealthy ones. Modern drivers of longevity (science and technology) enabling those with frailty to live longer. Dynamic equilibrium: DLE increasing but severity of ill health is reducing. Pushing back onset of frailty but maintaining that state for longer. Oxford Institute of Population Ageing Data – problematic Lack of harmonisation of health measures reduces comparisons § The Global Burden of Disease programme - estimate healthy life expectancy for 187 countries worldwide Disability Adjusted Life Years (DALY) (Chris Murry) § EU healthy life years (HLY), a DFLE § Global Activity Limitation Indicator (GALI) “Participation restriction”: World Health Organization International Classification of Functioning, Disability and Health. (Van Oyen et al., 2006; Berger et al., 2015) Oxford Institute of Population Ageing Changes (years) in life expectancy (LE) and health expectancies (HE) at birth, age 65 and age 85 based on different measures of ill health, Japan, Switzerland, UK and USA, men and women Measure of ill health LE Change (years) over time period Age 65 Age 85 HE LE HE LE HE 1995–2004 Activity limitation 2.3 1.2 1.7 0.8 1995–2004 2005–2009 1995–2004 ADL limitation Care needs Less than good health 2.3 2.0 1.7 0.8 1.7 1.3 0.2 −0.7 0.4 1.0 0.1 −0.3 2008–2012 Activity limitation 0.8 0.4 1.4 −0.1 0.8 2008–2012 Less than good health 0.4 0.5 −0.1 0.7 Birth Period Men Japan Switzerland UK 2001–2010 2.9 Disability 2.7 3.6 2.1 1.7 0.7 0.4 Less than good health 2.7 3.5 2.1 1.2 0.7 0.3 USA 2000–2006 Activity limitation 1.0 0.7 1.0 1.0 0.3 0.3 Japan 1995–2004 Activity limitation 1.7 0.8 2.3 0.8 1995–2004 2005–2009 ADL limitation Care needs 1.7 1.7 2.3 0.8 1.2 0.5 0.6 0.4 1995–2004 Less than good health 2.4 −0.7 1.4 −0.4 0.1 1.4 −0.2 −0.2 0.1 0.6 −0.2 −0.6 2001–2010 Women Switzerland 2008–2012 2008–2012 UK 2001–2010 2001–2010 USA 2000–2006 Activity limitation 0.3 3.0 Less than good health Disability 2.0 1.9 1.7 0.8 0.6 0.1 Less than good health 2.0 3.7 1.7 1.3 0.6 0.6 Activity limitation 0.9 0.5 0.7 0.8 0.3 0.3 Source: Hashimoto et al., 2010 (Japan); European Health and Life Expectancy Information System (Switzerland); Office for National Statistics (UK); Molla and Madans, 2010 (USA). Changes (years) in life expectancy (LE) and health expectancies (HE) at birth, age 65 and age 85 based on different measures of ill health, Japan, Switzerland, UK and USA, men and women Measure of ill health LE Change (years) over time period Age 65 Age 85 HE LE HE LE HE 1995–2004 Activity limitation 2.3 1.2 1.7 0.8 1995–2004 2005–2009 1995–2004 ADL limitation Care needs Less than good health 2.3 2.0 1.7 0.8 1.7 1.3 0.2 −0.7 Birth Period Men Japan 0.4 1.0 Source: Hashimoto et al., 2010 (Japan); European Health and Life Expectancy Information System (Switzerland); Office for National Statistics (UK); Molla and Madans, 2010 (USA). 0.1 −0.3 Changes (years) in life expectancy (LE) and health expectancies (HE) at birth, age 65 and age 85 based on different measures of ill health, Japan, Switzerland, UK and USA, men and women Birth Measure of ill health LE HE LE HE 1995– 2004 Activity limitation 2.3 1.2 1.7 0.8 1995– 2004 ADL limitation 2.3 2.0 1.7 1.3 2005– 2009 Care needs 0.8 1995– 2004 Less than good health 1.7 Period Men Japan Change (years) over time period Age 65 Age 85 LE HE 0.2 0.4 0.1 −0.7 1.0 −0.3 Source: Hashimoto et al., 2010 (Japan); European Health and Life Expectancy Information System (Switzerland); Office for National Statistics (UK); Molla and Madans, 2010 (USA). High correlation between life expectancy and healthy life expectancy for men in EU25+ countries 20 France Iceland 18 16 Life Expectancy at 65 14 CC=0.64 12 10 0 2 4 6 8 10 12 Healthy life expectancy at 65 Oxford Institute of Population Ageing 14 16 18 Eurostat 2009 data Change (years) in life expectancy (LE) and healthy life years (HLY) at birth, age 65 and age 85 between 2005 and 2010, men and women, selected EU countries. Birth Age 65 Age 85 LE HLY LE HLY LE HLY Italy 1.4 - 1.0 -1.8 0.5 0.2 France 1.5 −0.5 1.2 0.5 0.9 0.4 Poland 1.4 -2.7 0.8 -1.7 0.5 0.1 Denmark 1.2 -6.1 0.9 -1.4 0.3 -0.2 Hungary 2.0 4.1 0.8 0.3 0.7 0.02 EU27 1.6 0.7 1.1 0.1 0.7 1.5 Italy 1.1 - 1.0 -3.1 0.9 0.5 France 1.5 −1.2 1.4 0.1 1.4 1.7 Poland 1.4 -4.6 1.0 -2.7 0.9 -0.1 Denmark 0.9 -7 0.6 -1.2 0.2 -0.3 Hungary 1.4 4.3 1.0 0.9 0.6 -0.1 EU27 1.4 0.1 1.0 0 0.8 - Men Women Source: European Health and Life Expectancy Information System Life expectancy (LE) and healthy life years (HLY), selected EU countries and regions, men at Age 65 Age 65 20 EU (27) LE Denmark LE Remaining years of life 15 France LE Italy LE Hungary LE Poland LE 10 EU (27) HLY Denmark HLY France HLY 5 Italy HLY Hungary HLY Poland HLY 0 2004 2005 2006 2007 2008 2009 Source: European Health and Life Expectancy Information System 2010 2011 2012 2013 Life expectancy (LE) and healthy life years (HLY), selected EU countries and regions, men at Age 85 Age 85 8.0 Remaining years of life 7.0 EU (27) LE Denmark LE 6.0 France LE Italy LE 5.0 Hungary LE Poland LE 4.0 EU (27) HLY 3.0 Denmark HLY France HLY 2.0 Italy HLY Hungary HLY 1.0 Poland HLY 0.0 2004 2005 2006 2007 2008 2009 Source: European Health and Life Expectancy Information System 2010 2011 2012 2013 Three scenarios for changing relationship between life expectancy at 65 and disability-free life expectancy between 2006 and 2026 in the UK. Percentages refer to proportion of remaining life expectancy that is disability-free. It decreases in all scenarios. Life years without disability 2006 Ageing only 16.7 2026 90% 1.8 86% 90% 19.5 5 86% 3.1 16.7 2026 0 1.8 18.5 2006 90% 3 16.7 2026 Improving health 1.8 18.8 2006 Poorer health Life years with disability 10 2.9 15 Oxford Institute of Population Ageing 20 87% 25 Source: C Jagger, R Matthews. 2008 findings from ESRC IMAP 2030 project Change in dementia prevalence over time. Wu et al, 2015 Dementia in Western Europe: epidemiological evidence and implications for policy making, The Lancet Oxford Institute of Population Ageing !! Will increases in both life expectancy and in life extension or longevity continue? !! !! will there be an increase in average years lived by humans and also maximum years attained by a human being? Will life expectancy increase in line with life extension? !! will we all enjoy the benefits of longevity or will it be for a few? The Inequality question !! Will increases in life expectancy be accompanied by increases in life extension or are we seeing a compression of longevity after 100? !! Will advances in life expectancy be matched by advances in healthy life expectancy? Oxford Institute of Population Ageing The inequality question ….. It was originally thought that social class differentials in mortality were to be understood mainly in terms of poverty measures: inadequate nutrition, overcrowded living conditions, poor sanitation and personal hygiene, and hazardous working conditions. Now evident that despite the considerable improvements in the standard of living of the lower socio-economic groups, there is still a large gap in LE and larger (increasing) in HLE Social gradient in mortality risk: lower income groups within a society have a higher mortality rate, despite being well above the poverty line. Oxford Institute of Population Ageing Inequalities and Life Course ‘ § Foetal origins hypothesis’, which links impaired foetal growth with increased risk of cardiovascular mortality. § There is also a clear relationship between marital status and mortality risk: married people tend to have better health and to live longer than never-married people, who in turn do somewhat better than the divorced or widowed. § Most recently social class, unemployment and education were found to be strongly related to variation in LE and DFLE at birth but were less influential in explaining variations at age 85. Oxford Institute of Population Ageing Inequality in Mortality Club Vita UK data set: 2 million Occupational Pension Records Oxford Institute of Population Ageing Rate ratios for age-standardised mortality rates for different socioeconomic and retirement categories (deaths per 100,000 pop) Regional distribution of factors associated with high mortality in men and womena (percentages) Comparison of life expectancy top and bottom salary quintiles for different regions Comparison of life expectancy top and bottom Carstairs quintiles for different regions DevianceAnalysis Differential longevity Comparison of UK life expectancies from age 65 Men Low 12.0 Low income Ill health retiree Unhealthy lifestyle High 23.0 Difference 11.0 years High income Normal health retiree Healthy lifestyle Source: Oxford Institute of Population Ageing Oxford Institute of Population Ageing Proportion of 65 year old men expected to survive to each older age % probability of reaching age x 100 Unhealthy lifestyle, ill health retiree, poor Healthy lifestyle, normal health retiree, rich ‘Average’ individual 75 50 25 0 65 75 Age 85 Oxford Institute of Population Ageing 95 Source: Oxford Institute of Population Ageing Impact of different factors on longevity 12 Manual employee, poor, unhealthy lifestyle, ill health retiree if he did a non-manual job 0.7 if he retired in normal health 1.8 4 if he also had a high income 4.6 if he also had a healthy lifestyle 0 5 10 15 20 Remaining Expectancy from age 65 25 Will increases in both life expectancy and in life extension or longevity continue? will there be an increase in average years lived by humans and also maximum years attained by a human being? Will life expectancy increase in line with life extension? will we all enjoy the benefits of longevity or will it be for a few? The Inequality question !! Will increases in life expectancy be accompanied by increases in life extension or are we seeing a compression of longevity after 100? Will advances in life expectancy be matched by advances in healthy life expectancy? Oxford Institute of Population Ageing Determinants of the shape of mortality and morbidity in 21st Century § § § § Healthy Living Disease Prevention and Cure Regenerative medicine Age-Retardation. Key Question How much life expectancy can we expect to gain without the intensive application of scientific medicine? Estimate the impact on life expectancy of delaying the onset of what we know to be age-related diseases rather than eliminating them altogether. Oxford Institute of Population Ageing Centenarians Will increases in life expectancy be accompanied by increases in life extension or are we seeing a compression of longevity after 100? Oxford Institute of Population Ageing Centenarians Oxford Institute of Population Ageing Centenarians Projected number of centenarians in the USA 6m 5m 4m 3m 2m 1m >1m 2010 2020 2030 2040 2050 2060 2070 2080 Source: Oxford Institute of Population Ageing Statistics Oxford Institute of Population Ageing Oxford Institute of Population Ageing Source: Christiansen et al Lancet 2009 Determinants of the shape of mortality and morbidity in 21st Century § § § § Healthy Living Disease Prevention and Cure Regenerative medicine Age-Retardation. Key Question How much life expectancy can we expect to gain with the intensive application of scientific medicine? Oxford Institute of Population Ageing Bio-Technology Oxford Institute of Population Ageing Reprogramming Skin Cell Stem Cells Human Therapeutic cell type Picture: Time (left) Paul J Fairchild, Dunn School of Pathology (right) Oxford Institute of Population Ageing Oxford Institute of Population Ageing The Challenge…… Thechallengeinallregionsishowtosustainand enhancewell-beingacrossanindividual’slife,while atthesamePmereducingtheinequaliPeswithin eachgeneraPon,andensuringanequitable reallocaPonofresourcesbetweenthegeneraPons. Oxford Institute of Population Ageing www.ageing.ox.ac.uk Oxford Institute of Population Ageing Picture: Nasir Hamid/Oxford University Oxford Institute of Population Ageing
© Copyright 2026 Paperzz